Search
-
Member Alert - March 8, 2021
Member Services > Member Alerts > Archived Member Alerts > Member Alert March 8 2021
Action Required: All manufacturers that are currently or have the potential to contribute dairy ingredients to composite products (see below) exported to the EU or transiting the EU must now register with FDA to be added to the EU-approved plant list. Regulatory Change: The new composite health and
-
Global Dairy eBrief Exclusive 3/10/2020
Member Services > Periodicals > Global Dairy Ebrief Exclusives Articles > Global Dairy Ebrief Exclusive 3 > 10 > 2020 - by Tom Vilsack
Dear USDEC Members, Out of concern for the health and welfare of our members and our USDEC team, the in-person Board Meeting is cancelled and we will hold it as a webinar, instead. Due to the recent outbreaks of the coronavirus COVID-19 in Chicago and around the world, we have decided, following inp
-
Mexico Final Cheese Technical Regulation Published
Market Access & Regulatory Affairs > Hot Topics Folder > Hot Topics > Hot Topics > Mexico Final Cheese Technical Regulation Published
Mexico’s government published the final version of the new compositional technical regulation for cheese
-
Global Dairy eBrief Exclusive 02/05/2018
Member Services > Periodicals > Global Dairy Ebrief Exclusives Articles > Archives > Global Dairy Ebrief Exclusive 02 > 05 > 2018 - by Margaret Speich
These are now provided monthly by Edelman Shanghai as part of the news monitoring we do for issues and crisis management in Asia. We are pleased to extend this information to our wider USDEC membership to serve as a quick and informative compilation of regional headlines and potential trends in As
-
Member Alert - August 17, 2017
Member Services > Member Alerts > Archived Member Alerts > Member Alert August 17 2017
FDA is updating both its China and European Union (EU) plant lists.
-
Global Dairy eBrief Exclusive 06/25/2018
Member Services > Periodicals > Global Dairy Ebrief Exclusives Articles > Archives > Global Dairy Ebrief Exclusive 06 > 25 > 2018 - by Margaret Speich
Thirty-six years later, Johnson & Johnson's handling of the Tylenol situation in 1982 remains the textbook example of how to respond to a crisis. Johnson & Johnson quickly pulled 31 million bottles of Tylenol—worth $100 million—off the shelves, and it became obvious right awa